Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women

NCT01511835 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2012-01-19

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy of myo-inositol in preventing gestational diabetes in high risk pregnant women.

Conditions

  • Gestational Diabetes

Interventions

DIETARY_SUPPLEMENT

inositol + folic acid

2000 mg of inositol+200mcg of folic acid; 2 per diem

DIETARY_SUPPLEMENT

inositol + folic acid

600 mg of inositol + 200mcg of folic acid; 2 cp per diem

DRUG

Folic Acid

Folic Acid 400mcg; 1 cp/die

Sponsors & Collaborators

  • AGUNCO Obstetrics and Gynecology Centre

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01511835 on ClinicalTrials.gov